ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Ste Virbac SA (PK)

Ste Virbac SA (PK) (VRBCF)

408,00
0,00
( 0,00% )
Aktualisiert: 19:45:51

Ste Virbac SA (PK) (VRBCF) Aktie

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
408,00
( - )
Gebot
382,60
Fragen
414,30
Volumen
-
0,00 Tagesbereich 0,00
346,00 52-Wochen-Bereich 436,32
Marktkapitalisierung
Handelsende
408,00
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
-
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
US$ 4.668
Ausgegebene Aktien
8.377.824
Dividendenrendite (LTM)
1,45 (0,40%)
Kurs-Gewinn-Verhältnis
19,44
Gewinn pro Aktie (EPS)
18
Erlöse (LTM)
1,46B
Nettogewinn (LTM)
150,89M

Über Ste Virbac SA (PK)

Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Pacific. The company offers Vikaly, a cat food designed for the management of feline... Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Pacific. The company offers Vikaly, a cat food designed for the management of feline chronic kidney disease; Prevexto that contains imidacloprid and flumethrin, providing long-lasting parasite protection collar for dogs and cats at risk of fleas, ticks, lice, and sandflies; Zenidog/Zenifel offers a fogger, spray, and non-electric pheromone gel diffuser to soothe and reduce stress-related behaviors in dogs; Suigen Entero 3 is an inactivated vaccine aimed at preventing neonatal diarrhea in piglets caused by colibacillosis, clostridium, and rotavirus; Ursolyx soft chews formulated with ursolic acid that support muscle strength and mobility in dogs and cats; Zenifel a fogger and spray designed to reduce behaviors due to stress or undesirable behaviors in cats; Suigen PCV2 is a vaccine for porcine circovirus type 2; and Suigen Donoban is a multivalent vaccine used for the prevention of respiratory diseases in swine. It also provides a range of vaccines, antibiotics, parasiticides, and anti-inflammatory drugs, as well as dermatology, dental, specialty, diagnosis, immunology, nutrition, petfood, and pharmaceutical products. In addition, the company serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France. Mehr anzeigen

Sektor
Healthcare
Branche
Pharmaceuticals
Hauptsitz
Carros, France
Gegründet
1968
Ste Virbac SA (PK) is listed in the Healthcare sector of the OTC Markets with ticker VRBCF. The last closing price for Ste Virbac (PK) was US$408,00. Over the last year, Ste Virbac (PK) shares have traded in a share price range of US$ 346,00 to US$ 436,32.

Ste Virbac (PK) currently has 8.377.824 shares in issue. The market capitalisation of Ste Virbac (PK) is US$3,42 billion. Ste Virbac (PK) has a price to earnings ratio (PE ratio) of 19.44.

VRBCF Neueste Nachrichten

Keine Nachrichten vorhanden.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000CS
40000000CS
1223.256.04288499025384.75408384.7513407.64230769CS
26-28.32-6.49064906491436.32436.32384.757407.64230769CS
526217.9190751445346436.323463408.49835821CS
156118.9641.1569332964289.04436.322889352.86837629CS
2606719.6480938416341436.322888353.04650633CS

VRBCF - Frequently Asked Questions (FAQ)

What is the current Ste Virbac SA (PK) share price?
The current share price of Ste Virbac SA (PK) is US$ 408,00
How many Ste Virbac SA (PK) shares are in issue?
Ste Virbac SA (PK) has 8.377.824 shares in issue
What is the market cap of Ste Virbac SA (PK)?
The market capitalisation of Ste Virbac SA (PK) is USD 3,42B
What is the 1 year trading range for Ste Virbac SA (PK) share price?
Ste Virbac SA (PK) has traded in the range of US$ 346,00 to US$ 436,32 during the past year
What is the PE ratio of Ste Virbac SA (PK)?
The price to earnings ratio of Ste Virbac SA (PK) is 19,44
What is the cash to sales ratio of Ste Virbac SA (PK)?
The cash to sales ratio of Ste Virbac SA (PK) is 2
What is the registered address of Ste Virbac SA (PK)?
The registered address for Ste Virbac SA (PK) is 13e rue LID - BP 27, Carros, Provence-Alpes-Côte d'Azur, 06511
What is the Ste Virbac SA (PK) website address?
The website address for Ste Virbac SA (PK) is corporate.virbac.com
Which industry sector does Ste Virbac SA (PK) operate in?
Ste Virbac SA (PK) operates in the Pharmaceuticals sector

VRBCF Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen